Markets
ENZ

Healthcare Stocks Narrowly Lower; Enzo Biochem Jumps 12% After Judge Upholds Big Jury Award

A generic image of a pen a chart
Credit: Shutterstock photo

Top Healthcare Stocks

JNJ -0.56%

PFE -0.44%

ABT -0.49%

MRK +0.10%

AMGN -1.38%

Healthcare stocks are narrowly lower with the NYSE Healthcare Sector Index falling about 0.2% and shares of healthcare companies in the S&P 500 down about 0.1% as a group.

In company news, Enzo Biochem Inc. ( ENZ ) is up more than 12% at $2.50 a share after saying a federal court judge in Connecticut last week upheld a $48.6-million jury award to be paid by Applera Corp., now Life Technologies Inc. LIFE shares are down about 0.1% at $74.78 each.

The Aug. 1 order by U.S. District Court Judge Janet Bond Arteron turned down a bid by LIFE seeking an alternative ruling on ENZ's assertion's Applera had infringed on patents covering compounds used in DNA sequencing systems used to read the genetic code.

According to ENZ, the ruling opens the way for it to recover prejudgment interest on the damages award, which it estimates could exceed $25 million in addition to the judgment.

In other sector news,

(+) CGEN, Enters a cancer research partnership with Bayer AG.

(-) ISIS, Prospective rheumatoid arthritis treatment did not show statistically significant results in a Phase 2 study.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

ENZ

Other Topics

Commodities

Latest Markets Videos